Metformin might curb Parkinson's risk in diabetes patients

04/16/2012 |

Adding metformin to sulfonylurea treatment may significantly cut the increased risk of Parkinson's disease seen in patients with diabetes, according to a study in Parkinsonism and Related Disorders. "An exciting aspect of the finding is that metformin seems to be working to protect the brain against neurodegeneration, which contributes to [Parkinsonism]. This means it may also be considered a relevant therapy for the prevention of dementia as well," lead author Mark Wahlqvist said.

View Full Article in:

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA